OTCMKTS:EXETF Extendicare (EXETF) Stock Price, News & Analysis $25.78 0.00 (0.00%) As of 07/2/2026 02:31 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendHeadlinesBuy This Stock About Extendicare Stock (OTCMKTS:EXETF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Extendicare alerts:Sign Up Key Stats Today's Range$25.62▼$25.7850-Day Range$20.54▼$25.7852-Week Range$8.62▼$25.95Volume48,121 shsAverage Volume30,440 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield1.86%Price TargetN/AConsensus RatingBuy Company Overview Extendicare Inc. (OTCMKTS:EXETF) is a Canada-based senior care provider headquartered in Markham, Ontario. The company specializes in the ownership and operation of long-term care homes, retirement residences and home health care services. It is publicly listed on the Toronto Stock Exchange under the symbol EXE and trades in the over-the-counter market as EXETF. Extendicare’s operations are organized into two primary segments. The Long-Term Care & Retirement Living division operates approximately 120 facilities under the Extendicare and EspritVitalité banners, serving residents in Ontario, Alberta, Saskatchewan and parts of Atlantic Canada. The Home Health Care segment provides in-home personal support, nursing and allied health services through its ParaMed brand, primarily in Ontario. Founded in 1962, the company has grown through a combination of strategic acquisitions and organic development of new care properties. Extendicare’s governance and senior leadership team bring extensive experience in healthcare management, with a focus on regulatory compliance, quality assurance and continuous improvement of resident and patient outcomes.AI Generated. May Contain Errors. Read More Extendicare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks10th Percentile Overall ScoreEXETF MarketRank™: Extendicare scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingBuy Consensus RatingExtendicare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageExtendicare has only been the subject of 2 research reports in the past 90 days.Read more about Extendicare's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is -99.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is -99.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Extendicare's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverExtendicare has a short interest ratio ("days to cover") of 224.34, which indicates bearish sentiment.Change versus previous monthShort interest in Extendicare has recently increased by 1.97%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 8.00%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth.Read more about Extendicare's dividend. News and Social MediaN/ANews SentimentN/A Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by Institutions9.44% of the stock of Extendicare is held by institutions.Read more about Extendicare's insider trading history. Receive EXETF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EXETF Stock News HeadlinesRBC Capital Remains a Buy on Extendicare (EXE)May 17, 2026 | theglobeandmail.comExtendicare Announces Voting Results for its 2026 Annual Meeting of ShareholdersApril 16, 2026 | globenewswire.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.July 5 at 1:00 AM | Profits Run (Ad)Extendicare Declares April 2026 Monthly Dividend for ShareholdersApril 15, 2026 | tipranks.comExtendicare Announces Closing of $450 Million Inaugural Offering of Investment Grade Senior Unsecured NotesApril 14, 2026 | globenewswire.comExtendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured NotesApril 9, 2026 | globenewswire.comExtendicare Sets Date for Q1 2026 Results and Investor CallApril 6, 2026 | tipranks.comExtendicare Announces Timing of 2026 First Quarter Results and Conference CallApril 6, 2026 | globenewswire.comSee More Headlines EXETF Stock Analysis - Frequently Asked Questions How have EXETF shares performed this year? Extendicare's stock was trading at $15.5350 at the beginning of 2026. Since then, EXETF stock has increased by 65.9% and is now trading at $25.78. How do I buy shares of Extendicare? Shares of EXETF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/05/2026Next Earnings (Estimated)8/06/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryTrading Current SymbolOTCMKTS:EXETF CIKN/A Webwww.extendicare.com Phone(905) 470-4000FaxN/AEmployees23,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (OTCMKTS:EXETF) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.